New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
16:41 EDTMDT, EWAppeals ruling a significant legal victory for Edwards, says Wells Fargo
Wells Fargo said it views today's appeals court ruling as a significant legal victory for Edwards Lifesciences (EW), noting it's the third favorable court ruling for Edwards in its litigation with Medtronic's (MDT) CoreValve. Wells estimates the upside to Edwards Lifesciences from the litigation could be about $486M after tax, or $4.11 per share. The firm continues to expect both companies to negotiate a settlement which would allow Medtronic to enter the U.S. market once CoreValve receives approval towards the end of 2014. Wells Fargo has an Outperform rating on Edwards Lifesciences.
News For EW;MDT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 27, 2015
06:59 EDTMDTMedtronic volatility flat into Q2 and outlook
Subscribe for More Information
November 24, 2015
08:31 EDTMDTMedtronic remains a top tier performer in Med Device space, says Cowen
Subscribe for More Information
November 20, 2015
05:22 EDTMDTStocks with implied volatility movement; MDT UNH
Stocks with implied volatility movement; Medtronic (MDT) 25, UnitedHealth (UNH) 30 according to iVolatility.
November 19, 2015
16:34 EDTEWEdwards Lifesciences approves two-for-one stock split
Edwards Lifesciences approved a two-for-one split of the company's outstanding shares of common stock to be effected as a 100% stock dividend. This will be the company's second stock split since it went public in April 2000. Stockholders of record at the close of business on November 30 will be issued one additional share of common stock for each share owned as of that date. The additional shares will be distributed on December 11. The stock split will increase the number of common shares outstanding from approximately 108M shares as of the record date, to approximately 216M shares.
November 17, 2015
09:14 EDTMDTMedtronic announces FDA approval, launch of MyCareLink Smart Monitor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use